Transgenic refractory Aedes aegypti lines are resistant to multiple serotypes of dengue virus

The areas where dengue virus (DENV) is endemic have expanded rapidly, driven in part by the global spread of Aedes species, which act as disease vectors. DENV replicates in the mosquito midgut and is disseminated to the mosquito’s salivary glands for amplification. Thus, blocking virus infection or replication in the tissues of the mosquito may be a viable strategy for reducing the incidence of DENV transmission to humans. Here we used the mariner Mos1 transposase to create an Aedes aegypti line that expresses virus-specific miRNA hairpins capable of blocking DENV replication. These microRNA are driven by the blood-meal-inducible carboxypeptidase A promoter or by the polyubiquitin promoter. The transgenic mosquitoes exhibited significantly lower infection rates and viral titers for most DENV serotypes 7 days after receiving an infectious blood meal. The treatment was also effective at day 14 post infection after a second blood meal had been administered. In viral transmission assay, we found there was significantly reduced transmission in these lines. These transgenic mosquitoes were effective in silencing most of the DENV genome; such an approach may be employed to control a dengue fever epidemic.

Truncated Expression of a Carboxypeptidase A from Bovine Improves Its Enzymatic Properties and Detoxification Efficiency of Ochratoxin A

Ochratoxin A (OTA) is a toxic secondary metabolite produced mainly by Penicillium spp. and Aspergillus spp. and commonly found in foodstuffs and feedstuffs. Carboxypeptidase A (CPA) can hydrolyze OTA into the non-toxic product ochratoxin α, with great potential to realize industrialized production and detoxify OTA in contaminated foods and feeds. This study constructed a P. pastoris expression vector of mature CPA (M-CPA) without propeptide and signal peptide. The results showed that the degradation rate of OTA by M-CPA was up to 93.36%. Its optimum pH was 8, the optimum temperature was 40 °C, the value of Km was 0.126 mmol/L, and the maximum reaction rate was 0.0219 mol/min. Compared with commercial CPA (S-CPA), the recombinant M-CPA had an improve stability, for which its optimum temperature increased by 10 °C and stability at a wide range pH, especially at pH 3–4 and pH 11. M-CPA could effectively degrade OTA in red wine. M-CPA has the potential for industrial applications, such as can be used as a detoxification additive for foods and feeds.

Reducing Ochratoxin A Content in Grape Pomace by Different Methods

Grape pomace (GP) is the residue of grapes after wine making and is a valuable source of dietary polyphenol and fiber for health promotion. However, studies found the presence of ochratoxin A (OTA) in GP at very high concentrations, which raises a safety issue in the value-added utilization of GP. This study evaluated the effects of thermal pressure, baking, acid and enzymatic treatments on OTA content in GP. Thermal pressure treatment was conducted with wet GP at 121 °C for 10–30 min in an autoclave; acid treatments were conducted with hydrochloric acid, acetic acid, citric acid, and lactic acid, respectively, at 50 °C for 24 h. Baking was conducted using a cookie model. For enzymatic treatment, purified OTA solution was treated with carboxypeptidase A, alcalase, flavourzyme, pepsin, and lipase, respectively, and the effective enzymes were selected to treat GP. Results show that autoclaving for 10–30 min reduced 19–80% of OTA, varying with treatment time and GP variety. The effectiveness of acid treatment was similar to that of autoclaving and varied with acid type and GP variety. Baking increased the detectable OTA. Among all tested enzymes, carboxypeptidase A was the most effective in reducing OTA, followed by lipase and flavourzyme, but their effects were significantly lower in GP samples.